Journal of Commercial Biotechnology

Leading thinking on biotechnology business management

Journal of Commercial Biotechnology

The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.



Vol 20, No 3 (2014)

Open Access Open Access  Restricted Access Subscription or Fee Access

Table of Contents

Commentary

Who Lost Opioids? PDF
Peter J. Pitts
GM tea: the need of the hour to reclaim India’s leading position in the global tea market PDF
Debajit Borah, Amrita Kashyap Chaliha, Dhrubajyoti Gogoi, RNS Yadav

Articles

What makes a happy team? Data from 5 years’ entrepreneurship teaching suggests that working style is a major determinant of team contentment. PDF
William Bains
Ethical, Legal, and Regulatory Issues Regarding the Study and Use of Medications in Pregnant Women PDF
Diana Pham

From the Classroom

The University of Colorado Digital Health Consortium Initiative: A Collaborative Model of Education, Research and Service PDF
Jiban Khuntia, Jahangir Karimi, Mohan Tanniru, Arlen Meyers

Legal and Regulatory Updates

Staking an Advantage in an AIA World: Practical Patent Tips for Biotechnology Companies PDF
Stefan Michael Miller
USPTO Guidance On Patentable Subject Matter: Impediment to Biotech Innovation? PDF
Joanna T. Brougher, David A. Fazzolare
EU Legal & Regulatory Update – June 2014 PDF
Ewan Grist

Conference Report

Four Perspectives on Business Model Evolution in Synthetic Biology PDF
Karl Schmieder, Clara Andrew-Wani

Book Reviews

India's Healthcare Industry: Innovation in Delivery, Financing, and Manufacturing PDF
Susan Finston